65 related articles for article (PubMed ID: 7998906)
1. Rules governing peptide-class II MHC molecule interactions.
Hammer J; Nagy ZA; Sinigaglia F
Behring Inst Mitt; 1994 Jul; (94):124-32. PubMed ID: 7998906
[No Abstract] [Full Text] [Related]
2. Editing of the HLA-DR-peptide repertoire by HLA-DM.
Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
[TBL] [Abstract][Full Text] [Related]
3. T cell recognition of MHC class II-associated peptides is independent of peptide affinity for MHC and sodium dodecyl sulfate stability of the peptide/MHC complex. Effects of conservative amino acid substitutions at anchor position 1 of influenza matrix protein19-31.
Wu S; Gorski J; Eckels DD; Newton-Nash DK
J Immunol; 1996 May; 156(10):3815-20. PubMed ID: 8621918
[TBL] [Abstract][Full Text] [Related]
4. Changing ABRA protein peptide to fit into the HLA-DRbeta1*0301 molecule renders it protection-inducing.
Salazar LM; Alba MP; Curtidor H; Bermúdez A; Luis E Vargas ; Rivera ZJ; Patarroyo ME
Biochem Biophys Res Commun; 2004 Sep; 322(1):119-25. PubMed ID: 15313182
[TBL] [Abstract][Full Text] [Related]
5. Production of soluble MHC class II proteins with covalently bound single peptides.
Kozono H; White J; Clements J; Marrack P; Kappler J
Nature; 1994 May; 369(6476):151-4. PubMed ID: 8177320
[TBL] [Abstract][Full Text] [Related]
6. Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands.
Marshall KW; Liu AF; Canales J; Perahia B; Jorgensen B; Gantzos RD; Aguilar B; Devaux B; Rothbard JB
J Immunol; 1994 May; 152(10):4946-57. PubMed ID: 8176213
[TBL] [Abstract][Full Text] [Related]
7. Suppression of allorecognition by use of synthetic peptides.
Colovai AI; Renna-Molajoni E; Cocciolo PL; Tugulea S; Liu Z; Harris PE; Suciu-Foca N; Cortesini R
Transplant Proc; 1996 Dec; 28(6):3029-31. PubMed ID: 8962175
[No Abstract] [Full Text] [Related]
8. A predictive method for the evaluation of peptide binding in pocket 1 of HLA-DRB1 via global minimization of energy interactions.
Androulakis IP; Nayak NN; Ierapetritou MG; Monos DS; Floudas CA
Proteins; 1997 Sep; 29(1):87-102. PubMed ID: 9294869
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of HLA-DRA1*0101/DRB1*0401 molecules expressed in Drosophila melanogaster cells.
Hansen BE; Andersson EC; Madsen LS; Engberg J; Søndergaard L; Svejgaard A; Fugger L
Tissue Antigens; 1998 Feb; 51(2):119-28. PubMed ID: 9510368
[TBL] [Abstract][Full Text] [Related]
10. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices.
Sturniolo T; Bono E; Ding J; Raddrizzani L; Tuereci O; Sahin U; Braxenthaler M; Gallazzi F; Protti MP; Sinigaglia F; Hammer J
Nat Biotechnol; 1999 Jun; 17(6):555-61. PubMed ID: 10385319
[TBL] [Abstract][Full Text] [Related]
11. A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules.
Kropshofer H; Vogt AB; Thery C; Armandola EA; Li BC; Moldenhauer G; Amigorena S; Hämmerling GJ
EMBO J; 1998 Jun; 17(11):2971-81. PubMed ID: 9606180
[TBL] [Abstract][Full Text] [Related]
12. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
[TBL] [Abstract][Full Text] [Related]
13. Peptide binding to the HLA-DRB1 supertype: a proteochemometrics analysis.
Dimitrov I; Garnev P; Flower DR; Doytchinova I
Eur J Med Chem; 2010 Jan; 45(1):236-43. PubMed ID: 19896246
[TBL] [Abstract][Full Text] [Related]
14. Multiple binding sites on the superantigen, staphylococcal enterotoxin B, imparts versatility in binding to MHC class II molecules.
Soos JM; Johnson HM
Biochem Biophys Res Commun; 1994 Jun; 201(2):596-602. PubMed ID: 8002991
[TBL] [Abstract][Full Text] [Related]
15. High non-protective, long-lasting antibody levels in malaria are associated with haplotype shifting in MHC-peptide-TCR complex formation: a new mechanism for immune evasion.
Patarroyo ME; Bermúdez A; Salazar LM; Espejo F
Biochimie; 2006 Jul; 88(7):775-84. PubMed ID: 16483708
[TBL] [Abstract][Full Text] [Related]
16. Use of antagonist peptides to inhibit in vitro T cell responses to Par j1, the major allergen of Parietaria judaica pollen.
De Palma R; Wu S; Sallusto F; Di Felice G; Martucci P; Geraci D; Colombo P; Troise C; Sacerdoti G; Nocera A; Gorski J
J Immunol; 1999 Feb; 162(4):1982-7. PubMed ID: 9973468
[TBL] [Abstract][Full Text] [Related]
17. A mannose 6-phosphate-containing N-linked glycopeptide derived from lysosomal acid lipase is bound to MHC class II in B lymphoblastoid cell lines.
Dustin ML; McCourt DW; Kornfeld S
J Immunol; 1996 Mar; 156(5):1841-7. PubMed ID: 8596035
[TBL] [Abstract][Full Text] [Related]
18. An integrin polymorphism that defines reactivity with alloantibodies generates an anchor for MHC class II peptide binding: a model for unidirectional alloimmune responses.
Wu S; Maslanka K; Gorski J
J Immunol; 1997 Apr; 158(7):3221-6. PubMed ID: 9120277
[TBL] [Abstract][Full Text] [Related]
19. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.
Kobayashi H; Nagato T; Takahara M; Sato K; Kimura S; Aoki N; Azumi M; Tateno M; Harabuchi Y; Celis E
Cancer Res; 2008 Feb; 68(3):901-8. PubMed ID: 18245493
[TBL] [Abstract][Full Text] [Related]
20. Identification of a promiscuous HLA DR-restricted T-cell epitope derived from the inhibitor of apoptosis protein survivin.
Piesche M; Hildebrandt Y; Zettl F; Chapuy B; Schmitz M; Wulf G; Trümper L; Schroers R
Hum Immunol; 2007 Jul; 68(7):572-6. PubMed ID: 17584578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
